Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 5/2010

01.05.2010 | Brief Report

Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996–2009

verfasst von: H. Araoka, M. Baba, A. Yoneyama

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Stenotrophomonas maltophilia is an important nosocomial pathogen, especially among immunocompromised patients. The objective of this study was to clarify the clinical characteristics, prognosis, and prognostic factors of patients with S. maltophilia bacteremia in Japan. The microbiology records of all patients with S. maltophilia bacteremia between January 1996 and April 2009 at Toranomon Hospital, Tokyo, Japan, were retrospectively reviewed. A total of 53 cases of bacteremia were identified. Thirty patients had an underlying hematological disorder, and 23 were receiving hematopoietic transplantation. The overall mortality rate was 51%. On univariate analysis, neutropenia (p < 0.01), the presence of a central venous catheter, and mixed infection with enterococci (p < 0.05) were significantly related to the mortality. Among these variables, neutropenia (p < 0.01) and mixed infection with enterococci (p < 0.05) were independent factors associated with mortality. In contrast, all eight patients in whom S. maltophilia was the etiologic agent of catheter-related infection survived following catheter removal. S. maltophilia is an important pathogen among immunocompromised patients, especially in the neutropenic phase or mixed infection with enterococci. If a central venous catheter was present at the onset of S. maltophilia bacteremia, the prompt removal of the catheter was important.
Literatur
2.
Zurück zum Zitat Elting LS, Bodey GP, Fainstein V (1986) Polymicrobial septicemia in the cancer patient. Medicine 65:218–225CrossRefPubMed Elting LS, Bodey GP, Fainstein V (1986) Polymicrobial septicemia in the cancer patient. Medicine 65:218–225CrossRefPubMed
3.
Zurück zum Zitat Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S, Martino P (2000) Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 31:705–711. doi:10.1086/314043 CrossRefPubMed Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S, Martino P (2000) Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis 31:705–711. doi:10.​1086/​314043 CrossRefPubMed
4.
Zurück zum Zitat Lai CH, Chi CY, Chen HP, Chen TL, Lai CJ, Fung CP, Yu KW, Wong WW, Liu CY (2004) Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect 37:350–358PubMed Lai CH, Chi CY, Chen HP, Chen TL, Lai CJ, Fung CP, Yu KW, Wong WW, Liu CY (2004) Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia. J Microbiol Immunol Infect 37:350–358PubMed
5.
Zurück zum Zitat Khan IA, Mehta NJ (2002) Stenotrophomonas maltophilia endocarditis: a systematic review. Angiology 53:49–55CrossRefPubMed Khan IA, Mehta NJ (2002) Stenotrophomonas maltophilia endocarditis: a systematic review. Angiology 53:49–55CrossRefPubMed
6.
Zurück zum Zitat Papadakis KA, Vartivarian SE, Vassilaki ME, Anaissie EJ (1997) Stenotrophomonas maltophilia meningitis. Report of two cases and review of the literature. J Neurosurg 87:106–108CrossRefPubMed Papadakis KA, Vartivarian SE, Vassilaki ME, Anaissie EJ (1997) Stenotrophomonas maltophilia meningitis. Report of two cases and review of the literature. J Neurosurg 87:106–108CrossRefPubMed
7.
Zurück zum Zitat Friedman ND, Korman TM, Fairley CK, Franklin JC, Spelman DW (2002) Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes. J Infect 45:47–53CrossRefPubMed Friedman ND, Korman TM, Fairley CK, Franklin JC, Spelman DW (2002) Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes. J Infect 45:47–53CrossRefPubMed
8.
Zurück zum Zitat Vartivarian SE, Anaissie EJ, Kiwan EN, Papadakis KA (2000) The clinical spectrum of Stenotrophomonas (Xanthomonas) maltophilia respiratory infection. Semin Respir Crit Care Med 21:349–355. doi:10.1055/s-2000-9859 CrossRefPubMed Vartivarian SE, Anaissie EJ, Kiwan EN, Papadakis KA (2000) The clinical spectrum of Stenotrophomonas (Xanthomonas) maltophilia respiratory infection. Semin Respir Crit Care Med 21:349–355. doi:10.​1055/​s-2000-9859 CrossRefPubMed
9.
Zurück zum Zitat Apisarnthanarak A, Mayfield JL, Garison T, McLendon PM, DiPersio JF, Fraser VJ, Polish LB (2003) Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case–control study. Infect Control Hosp Epidemiol 24:269–274. doi:10.1086/502197 CrossRefPubMed Apisarnthanarak A, Mayfield JL, Garison T, McLendon PM, DiPersio JF, Fraser VJ, Polish LB (2003) Risk factors for Stenotrophomonas maltophilia bacteremia in oncology patients: a case–control study. Infect Control Hosp Epidemiol 24:269–274. doi:10.​1086/​502197 CrossRefPubMed
10.
Zurück zum Zitat Labarca JA, Leber AL, Kern VL, Territo MC, Brankovic LE, Bruckner DA, Pegues DA (2000) Outbreak of Stenotrophomonas maltophilia bacteremia in allogenic bone marrow transplant patients: role of severe neutropenia and mucositis. Clin Infect Dis 30:195–197. doi:10.1086/313591 CrossRefPubMed Labarca JA, Leber AL, Kern VL, Territo MC, Brankovic LE, Bruckner DA, Pegues DA (2000) Outbreak of Stenotrophomonas maltophilia bacteremia in allogenic bone marrow transplant patients: role of severe neutropenia and mucositis. Clin Infect Dis 30:195–197. doi:10.​1086/​313591 CrossRefPubMed
Metadaten
Titel
Risk factors for mortality among patients with Stenotrophomonas maltophilia bacteremia in Tokyo, Japan, 1996–2009
verfasst von
H. Araoka
M. Baba
A. Yoneyama
Publikationsdatum
01.05.2010
Verlag
Springer-Verlag
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 5/2010
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-010-0882-6

Weitere Artikel der Ausgabe 5/2010

European Journal of Clinical Microbiology & Infectious Diseases 5/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.